Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €292.25 EUR
Change Today -0.25 / -0.09%
Volume 14.6K
ERF On Other Exchanges
Symbol
Exchange
OTC US
EN Paris
Frankfurt
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

eurofins scientific (ERF) Snapshot

Open
€293.40
Previous Close
€292.50
Day High
€296.00
Day Low
€288.85
52 Week High
07/20/15 - €317.10
52 Week Low
10/16/14 - €163.00
Market Cap
4.5B
Average Volume 10 Days
18.4K
EPS TTM
€5.23
Shares Outstanding
15.3M
EX-Date
06/29/15
P/E TM
55.9x
Dividend
€1.32
Dividend Yield
0.45%
Current Stock Chart for EUROFINS SCIENTIFIC (ERF)

Related News

No related news articles were found.

eurofins scientific (ERF) Related Businessweek News

No Related Businessweek News Found

eurofins scientific (ERF) Details

Eurofins Scientific SE provides various analytical testing services to customers primarily in pharmaceutical, food, and environmental sectors worldwide. The company offers a portfolio of approximately 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. It provides food and feed testing services; biopharma services; pharma discovery services, including in vitro pharmacology profiling/screening services, vivo screening services, cell based assay services, and toxicity and pharmacokinetics services; preclinical services and early development Phase I and IIa studies; bioanalytical services; biomarker analysis services; pharmacogenetic/pharmacogenomics, biological safety testing, and assay development and validation services, as well as project consultancy and management services; and pharma central laboratory services. The company also offers biopharma product testing services; genomic services consisting of DNA and RNA oligonucleotides, custom DNA sequencing, next generation sequencing, gene synthesis and molecular biology, and genotyping and gene expression services; agro science services; consumer product testing services; forensic services, such as forensic DNA analysis and forensic toxicology; and environment testing services comprising water, soil, fuel, building materials, waste, air, and pollution testing services. In addition, it provides REACH testing and REACH consultancy services. The company operates approximately 200 laboratories in 36 countries. Eurofins Scientific SE was founded in 1987 and is headquartered in Luxembourg.

17,144 Employees
Last Reported Date: 02/26/15
Founded in 1987

eurofins scientific (ERF) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: €720.0K
Group Chief Technology Officer, Executive Dir...
Total Annual Compensation: €203.0K
Compensation as of Fiscal Year 2013.

eurofins scientific (ERF) Key Developments

Eurofins Scientific Provides Earnings Guidance for the Year 2015

Eurofins Scientific provided earnings guidance for the year 2015. The company expects to generate revenues of about EUR 140 million in 2015, and EBITDA margin in-line with Eurofins' objective.

Eurofins Scientific Signs an Agreement to Develop Bio-Access/Labazur Clinical

Eurofins Scientific announced that it has signed an agreement to take control, of Bio-Access, a group of clinical diagnostic laboratories in France, for an investment by Eurofins of approximately EUR 150 million plus ca. EUR 75 million of assumed debt. The transaction is expected to close within a few months, subject to fulfillment of specific conditions precedent, as well as other customary closing conditions and regulatory approvals, in particular the clearance from the French competition authority. Bio-Access provides Eurofins an entry platform into the complex European clinical diagnostic testing market, on which to deploy its technical know-how and proprietary technologies, including the competencies in specialty diagnostic testing that the Group has obtained, and continues to develop, following the acquisition of ViraCor, Boston Heart and Diatherix in the US.

Eurofins Scientific Launches DNA Chip Technology Enabling Identification of 21 Animal Species in Food and Feed

Eurofins Scientific launched a novel analytical method based on DNA chip technology which enables simultaneous detection and identification of up to 21 animal species in feed and food products. The molecular biology testing unit of Eurofins’ laboratory in Nantes has developed an innovative DNA chip testing method to expand the scope of analysis to multiple species in different food and feed matrices. Using mitochondrial DNA2 targets, the chip technology enables sensitive and reliable detection at low thresholds (0.1%) with a short turnaround time (5 working days from sample reception). With this fully-accredited3 test, specific and cost-effective detection of a large panel of species is now possible. The modular concept of the technology allows the identification of up to 21 meat species, according to customer needs, with only one test. The method has been specifically developed for meat and complex and/or processed food, as well as animal feed and pet food. With this new qualitative test, Eurofins provides unparalleled testing services for a wide range of species identification, including “species-specific” PCR to detect one particular species and other semi-quantitative tests to determine the proportions of the species contained in the product.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERF:FP €292.25 EUR -0.25

ERF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ERF.
View Industry Companies
 

Industry Analysis

ERF

Industry Average

Valuation ERF Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EUROFINS SCIENTIFIC, please visit www.eurofins.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.